📰 Low Dose News
Page 4 - Low Dose News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Low Dose. Real-time updates on events, politics, business and more.
May 25, 2023
New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial, are consistent with a good safety profile and long-term treatment effect of PXT3003 measured on
April 20, 2023
/PRNewswire/ -- MegaFood, a certified B Corporation celebrating its 50th anniversary of crafting nutrient-rich, planet-first vitamins and minerals paired with...
April 13, 2023
Nowadays launches as the first nationally available cannabis-infused spirit. Available in Low Dose and Micro Dose, Nowadays delivers a light and buzzy experience in a familiar format 750ml Bottle.
December 29, 2022
Protein powder is beneficial for runners and can aid in training and recovery. See the 2023 best protein powder for runners here.
December 22, 2022
Low-dose cone-beam CT (CBCT) yields statistically similar performance to standard-dose CBCT imaging protocols for CAD/CAM-guided dental implant surgery.
December 21, 2022
Low-dose cone-beam CT (CBCT) yields statistically similar performance to standard-dose CBCT imaging protocols for CAD/CAM-guided dental implant surgery.
December 9, 2022
Treatment with PDC*lung01 induces anti-tumor immune response in significant number of patients which appears to be enhanced by combination with pembrolizumab PDC*line Pharma, a clinical stage biotech
November 25, 2022
Cary Medical Center has received the second year of funding to increase awareness related to Low Dose CT Lung Cancer Screening. The award of $20,000 will help support a broad range of health information activities along with a professional education program in the spring of 2023.
October 3, 2022
Background The present study was conducted to assess the renal effects of high dose versus low dose lisinopril in patients with diabetic nephropathy. Methodology A prospective observational study was conducted at the Khyber Teaching Hospital, Peshawar, Khyber Pakhtunkhwa, Pakistan, between July 1, 2019, to January 1, 2020. Patients were divided into two groups. Group A patients were administered a low dose (5 mg per day) of Lisinopril and group B were administered a higher dose of therapy (20 mg...
September 20, 2022
2 chapters with information that could help save thousands if not millions of lives worldwide this winter for those suffering from COVID and Long COVID.